IQVIA
Combines healthcare intelligence and commercial technology with global clinical research services.
$261.75
After-hours close+0.08 (+0.03%)
At close$261.67(−0.27%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 125.73%Insiders 0.64%
A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.
Shares outstanding 164.60M · Float 156.25M · 94.9% free float
Institutions13F, as of Jun 30, 2026
1,118 holders · 206.95M shares · 138 new positions · 535 increased · 430 reduced · 120 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 14.55M | 8.84% | −477.8K | Aug 7, 2026 |
| Harris Associates L P | 12.18M | 7.40% | +555 | Aug 14, 2026 |
| Vanguard Capital Management LLC | 10.91M | 6.63% | −121.9K | Aug 13, 2026 |
| State Street Corp | 7.51M | 4.56% | +31.3K | Aug 7, 2026 |
| Vanguard Portfolio Management LLC | 7.50M | 4.56% | −74.0K | Aug 13, 2026 |
| JPMorgan Chase & Co | 6.14M | 3.73% | +732.1K | Aug 12, 2026 |
| Artisan Partners Limited Partnership | 4.74M | 2.88% | −315.4K | Aug 13, 2026 |
| Boston Partners | 4.47M | 2.71% | +227.1K | Aug 4, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Vanguard Capital Management | 7.49% | 12.71M | 13G | Apr 30, 2026 ↗ |
| Harris Associates L P | 6.80% | 11.75M | 13G | Aug 14, 2025 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Ari Bousbib | director, officer: See Remarks | 835.9K | 0.51% | Jul 31, 2026 |
| Ronald E. Bruehlman | officer: See Remarks | 44.1K | 0.03% | Feb 10, 2026 |
| John G. Danhakl | director | 30.6K | 0.02% | Apr 27, 2026 |
| Bernd Haas | officer: See Remarks | 24.4K | 0.01% | Feb 17, 2026 |
| Alistair Grenfell | officer: See Remarks | 24.1K | 0.01% | Feb 10, 2026 |
| Eric Sherbet | officer: See Remarks | 21.0K | 0.01% | Jul 31, 2026 |
| John M. Leonard | director | 16.9K | 0.01% | Apr 27, 2026 |
| Colleen A. Goggins | director | 14.5K | 0.01% | Apr 27, 2026 |
| W. Richard Staub | officer: See Remarks | 13.3K | 0.01% | Aug 4, 2026 |
| Michael J. Fedock | officer: See Remarks | 9.5K | 0.01% | Feb 17, 2026 |
8 ten-percent owners hold 46.40M shares by Form 4, outside the officers-and-directors figure above · 22 people have not refiled in the last 18 months (10.61M shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Jul 31, 2026 | Bhavik Patelofficer: See Remarks | Sale | 1,855 | $235.27 | 1,348 |
| Aug 3, 2026 | W. Richard Staubofficer: See Remarks | Sale | 5,500 | $232.68 | 13,312 |
| Jul 29, 2026 | Ari Bousbibdirector, officer: See Remarks | Sale · 4 lots | 106,279 | $245.51 | 885,868 |
| Jul 29, 2026 | Keriann Cherofskyofficer: See Remarks | Sale | 558 | $245.21 | 2,989 |
| Jul 29, 2026 | Eric Sherbetofficer: See Remarks | Sale | 5,000 | $249.16 | 20,999 |
| Dec 18, 2025 | Ari Bousbibdirector, officer: See Remarks | Sale | 36,564 | $222.43 | 820,599 |
| Oct 29, 2025 | Ari Bousbibdirector, officer: See Remarks | Sale · 6 lots | 56,557 | $220.33 | 828,198 |
| Oct 29, 2025 | Eric Sherbetofficer: See Remarks | Sale | 4,000 | $219.70 | 27,108 |
CongressHouse and Senate disclosures
Not reported.